INS and osteoarthritis: Additionally, GLP-1-based therapies, which enhance insulin secretion and improve glycemic control in DM, may exert protective effects in osteoarthritis by modulating inflammation, promoting cartilage repair mechanisms, and potentially slowing joint degeneration.